Atai Life Sciences Gross Margin 2020-2024 | ATAI
Atai Life Sciences Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2024-09-30 | $0.00B | 0 | nan% |
2024-06-30 | $0.00B | 0 | nan% |
2023-12-31 | $0.00B | 0 | nan% |
2023-09-30 | $0.00B | 0 | nan% |
2023-06-30 | $0.00B | 0 | nan% |
2023-03-31 | $0.00B | 0 | nan% |
2022-09-30 | $0.00B | 0 | nan% |
2022-06-30 | $0.00B | 0 | nan% |
2021-12-31 | $0.02B | $0.02B | 100.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Outpatient & Home Care | $0.200B | $0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Fresenius SE (FSNUY) | Germany | $19.704B | 11.92 |
Quest Diagnostics (DGX) | United States | $16.912B | 17.14 |
DaVita (DVA) | United States | $12.098B | 15.65 |
Encompass Health (EHC) | United States | $9.453B | 22.29 |
Chemed (CHE) | United States | $7.853B | 24.14 |
Elanco Animal Health (ELAN) | United States | $5.843B | 13.91 |
RadNet (RDNT) | United States | $5.284B | 117.02 |
Option Care Health (OPCH) | United States | $3.848B | 18.23 |
Amedisys (AMED) | United States | $2.744B | 19.53 |
LifeStance Health (LFST) | United States | $2.698B | 0.00 |
Addus HomeCare (ADUS) | United States | $2.350B | 27.57 |
Astrana Health (ASTH) | United States | $1.974B | 26.99 |
U.S Physical Therapy (USPH) | United States | $1.380B | 36.27 |
Pennant (PNTG) | United States | $0.938B | 37.92 |
Aveanna Healthcare Holdings (AVAH) | United States | $0.873B | 0.00 |
Bioqual (BIOQ) | United States | $0.059B | 0.00 |
Daxor (DXR) | United States | $0.039B | 0.00 |
Ontrak (OTRK) | United States | $0.006B | 0.00 |
MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
IMAC Holdings (BACK) | United States | $0.001B | 0.00 |
Psychemedics (PMD) | United States | $0.000B | 0.00 |